Aortic Repair Devices – Market Insights – Asia Pacific

The Asia Pacific market for aortic repair device market will expand at a modest rate over the forecast period, driven primarily by endovascular procedure volume growth and continued development and adoption of aortic stent grafts. However, endovascular procedure volume growth will be hindered to some extent by a lack of physicians trained in endovascular techniques, limited awareness and screening of aneurysms, and limited availability of modern healthcare facilities among some of the countries covered.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aortic repair devices in Europe from 2019 to 2032.

The aortic stent graft market is characterized by innovation, with companies launching products that enable the treatment of more complex aneurysms.

Which new products are entering the Asia Pacific market?

What impact will the launch of new stent grafts have on the competitive landscape?

Which indications will these products cover?

What impact will these products have on aortic surgical procedure volumes?

Treatment of aortic aneurysms is rising in the Asia Pacific countries due to improved healthcare infrastructure, contributing to procedure volumes.

Which segment of the aortic repair device market will see the greatest increase in procedure volumes through 2032?

For which indications will procedure volume growth be limited and which factors are limiting growth?

Which country will see the fastest procedure volume growth and which will see the slowest growth?

Aortic repair can be performed using endovascular, surgical, or hybrid procedures.

Which methods are preferred for which indications? How does this compare across the Asia Pacific countries?

What are the main drivers and limiters of growth in the endovascular device market?

For which indication will the growth of endovascular procedures be limited and why?

Which countries have the highest penetration of endovascular procedures?

Table of contents

Aortic Repair Devices - Market Insights - Asia Pacific

Pankhil Paresh Gandhi

Pankhil Gandhi is a senior team lead within the Cardiovascular Medtech Insights team at Clarivate, specializing in transcatheter embolization and occlusion devices and deep venous disease treatment devices markets. Pankhil holds a Doctor of Pharmacy degree from the Babasaheb Ambedkar Marathwada University, Aurangabad.

Contact sales Login to access report

Back to all Medtech Insights reports